New Report Reveals How the Covid Crisis Could Set Back a Generation of Women in Business

New Report Reveals How the Covid Crisis Could Set Back a Generation of Women in Business

Mastercard Index of Women Entrepreneurs demands innovative, gender-specific support for women throughout pandemic recovery

PURCHASE, N.Y.–(BUSINESS WIRE)–
Women across the world have been disproportionally impacted by the Covid-19 pandemic – a staggering 87% of women business owners say they have been adversely affected. Over representation in sectors hardest hit by the economic downturn, the pronounced digital gender gap in an increasingly virtual world, and the mounting pressures of childcare responsibilities are only a few factors that have left women particularly vulnerable.

In tackling this stark disparity and unlocking the fullest potential of women in business, the Mastercard Index of Women Entrepreneurs (MIWE) 2020 report findings make a compelling case for building on targeted gender-specific policy best practices internationally.

Gender-targeted policies drive forward women’s entrepreneurial success

Now in its fourth year, the MIWE highlights the vast socio-economic contributions of women entrepreneurs across the world, as well as providing insight on the factors driving and inhibiting their advancement. Through a unique methodology – drawing on publicly available data from leading international organisations, such as the OECD and International Labour Organization – MIWE 2020 includes a global ranking on the advancement of women in business in pre-pandemic conditions across 58 economies, representing almost 80% of the female labour force.

MIWE 2020’s top performing economy is a prime example of gender-specific support mechanisms having swift and significant results. For the first time in the MIWE’s history, Israel tops the charts as the best economy for women entrepreneurs worldwide, advancing from 4th place in 2019. With an ambition to double the number of female entrepreneurs within two years, Israel’s success has been driven by a focussed institutional backing for SMEs – its ‘Support for SMEs’ ranking catapulted from 42nd place in 2019, to 1st in 2020. Similarly, Switzerland has advanced from 11th position in 2019, to 3rd overall in 2020, spurred on by sharp improvement in government-led support for SMEs (up 37% from 2019) and a resulting uptick in cultural perceptions of entrepreneurialism (up 45% from 2019).

Covid-19 has posed set-backs, but also opportunity

MIWE 2020 also provides initial analysis on the ramifications of Covid-19 on women at work, and draws out effective support policies. Although differing from economy to economy, those proving most effective include expansive relief measures for SMEs – from wage subsidies to furlough schemes and fiscal bailouts – as well as state childcare support.

Crucially, the report presents an optimistic outlook for the future of women entrepreneurs. It indicates that the pandemic could prove a catalyst for exponential progress for women in business and an opportunity to course-correct inherent gender bias. It draws on a number of points to illustrate this, notably:

  • The Covid-19 era presents an empowering narrative for women in leadership, providing inspiration at a time when cultural barriers and fear of failure still impede some women from business ventures.Covid-19 has highlighted women’s ability to lead under extraordinary circumstances. Female world leaders such as Prime Minister Jacinda Ardern of New Zealand, Chancellor Angela Merkel of Germany and Prime Minister Sanna Marin of Finland have presided over some of the most successful efforts in containing Covid-19 while instilling order, assurance, trust and calm. With almost half (47.8%) of female entrepreneurs report being driven by a desire to contribute to the greater societal good, the impact these leaders have cannot be underestimated.
  • Women in business are already demonstrating marked adaptability, despite extensive barriers to success.On the frontline, women business owners are adapting to the new world of work with renewed confidence. 42% have shifted to a digital business model and 34% have identified new business opportunities since the pandemic.
  • The ‘next normal’ presents a once in a lifetime opportunity to remove existing barriers, driving greater gender participation and parity for women in business.As well as magnifying severalfold the many disparities women in business face – from the digital gender gap to financial inclusion – Covid-19 has been an intense stimulus for structural progress. For example, prior to the pandemic, the financial global gender disparity had remained static for almost a decade. However, Covid-19 has propelled progress in this area – with the UK government setting up bank accounts for over 1.2 million people in just two days at the height of the pandemic, and over 11 million informal workers in Brazil applied for saving accounts in order to receive emergency government funds.

The report notes that implications of these observations are profound. It further demonstrates the untapped value of women as leaders and, critically, highlights the role of the pandemic in expediating progressive solutions. Leveraging this momentum and championing gender-specific initiatives will be critical to realising women’s potential and winding down the $172 trillion lost globally (World Bank) due to the differences in lifetime earnings between women and men.

Mastercard’s commitment to driving forward inclusion

Sue Kelsey, Executive Vice President, Global Consumer Products and Financial Inclusion, Mastercard said: “A crisis will always reveal vulnerabilities in the system, and Covid-19 has done that in spades. We have seen the staggering extent of the disparity women in business face. But unlike any other economic downturn, Covid-19 has also paved the way for considerable progress and we have seen what we can be achieved when priority is given. However, are we brave enough to seize the opportunity, to listen to the data outlined in MIWE 2020 and act accordingly? Or will we cling on to a failed system, and allow the pandemic to shave off progress to date?

“These are critical questions decisions makers need to have at the fore as they plan their road to economic recovery. Collectively, governments, financial services and business organizations need to ensure they are offering the right support programmes, solutions and innovation to enable female entrepreneurs the opportunity to thrive in the world’s new normal.”

The MIWE report is just one component in Mastercard’s broader mission to drive forward the advancement of the disconnected and disadvantaged, with a particular commitment to support and help advance female entrepreneurs and small businesses through initiatives such as its Start Path and Path to Priceless programmes. In 2020, Mastercard expanded its worldwide financial inclusion commitment, pledging to bring a total of one billion people and 50 million micro and small businesses into the digital economy by 2025. As part of this effort, there will be a direct focus on providing 25 million women entrepreneurs with solutions that can help them grow their businesses, through a range of initiatives crossing funding, mentoring and the development of inclusive technologies.

Download the Mastercard Index of Women Entrepreneurs 2020 report and supporting assets here. Read more about our efforts to engage, enable and empower women here.

MIWE methodology

The Mastercard Index of Women Entrepreneurs provides world-leading analysis on how women in business are progressing across 58 global economies. Representing almost 80 percent of the international female labour force, the MIWE provides deep-dive analysis on the socioeconomic factors propelling and inhibiting their success.

Through a unique methodology – involving detailed analysis across 12 indicators and 25 sub-indicators spanning Advancement Outcomes, Knowledge Assets & Financial Access, and Supporting Entrepreneurial Conditions – the index ranks 58 individual economies according to performance over the past year. Aggregating these scores, the index is able to provide an overall grading of how successful individual economies are in advancing female entrepreneurialism in comparison to peers in pre-Covid conditions.

This year’s report also provides additional analysis on the early ramifications of emergency measures implemented by governments and business for women entrepreneurs in response to the Covid-19 pandemic across 40 global economies.

The Mastercard Index of Women Entrepreneurs findings provide clarity and understanding for governments, policymakers, stakeholders, businesses and individuals alike wishing to understand the crucial role of women in business and apply learnings from global economies.

About Mastercard

Mastercard (NYSE: MA) is a global technology company in the payments industry. Our mission is to connect and power an inclusive, digital economy that benefits everyone, everywhere by making transactions safe, simple, smart and accessible. Using secure data and networks, partnerships and passion, our innovations and solutions help individuals, financial institutions, governments and businesses realize their greatest potential. Our decency quotient, or DQ, drives our culture and everything we do inside and outside of our company. With connections across more than 210 economies, we are building a sustainable world that unlocks priceless possibilities for all.

Rose Beaumont | +44 (20) 7557 5199| [email protected]

Julia Monti | +1 (914) 249 6135| [email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Consumer Small Business Women Finance Banking

MEDIA:

Logo
Logo

New book shares insights on how to build great teams and develop a new level of teamwork in organizations

Leo Bottary releases ‘Peernovation: What Peer Advisory Groups Can Teach Us about Building High-Performing Teams’

CARLSBAD, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) — Author Leo Bottary continues his mission to leverage the power of peers both in business and in life. Following up his two self-improvement books, he now releases “Peernovation: What Peer Advisory Groups Can Teach Us about Building High-Performing Teams” (published by Archway Publishing).

 

“Peernovation” combines the words peer (people) and innovation (creativity realized). It embraces lessons from more than a decade of academic research, fieldwork and personal experiences throughout North America and the United Kingdom. “In today’s divisive society, we need to reassure business leaders and their employees that we’re all in this together. Realizing our greatest aspirations will only happen if we embrace our diversity and work as one. By leveraging best practices from CEO and executive peer advisory groups, ‘Peernovation’ shows us how to do that, whether our teams work virtually or in-person,” Bottary states. The book is designed for leaders who want to coach engaged, adaptable and higher-performing teams. Here, they will learn to:

  • select the right people for your team
  • create psychological safety and inspire greater productivity
  • build a positive culture of accountability
  • become a better team leader
  • foster a robust learning-achieving cycle

 

Forbes publisher and futurist Rich Karlgaard noted, “In a post-COVID world, and with the emergence of AI across even more industries, “Peernovation” reminds us of what doesn’t change – our humanity and our ability to collaborate and create. These will be the keys to thriving in the decades to come.”

 

Visit https://www.archwaypublishing.com/en/bookstore/bookdetails/810115-peernovation to purchase a copy of the book.

 

“Peernovation: What Peer Advisory Groups Can Teach Us about Building High-Performing Teams”

By Leo Bottary

Hardcover | 6 x 9in | 160 pages | ISBN 9781480895683

Softcover | 6 x 9in | 160 pages | ISBN 9781480895669

E-Book | 160 pages | ISBN 9781480895676

Available at Amazon and Barnes & Noble

 

About the Author

Leo Bottary is the founder and managing partner of Peernovation, LLC. A popular author, keynote speaker and workshop facilitator, Bottary is an instructor for Rutgers University and an opinion columnist for CEOWORLD Magazine. He is the co-author of “The Power of Peers: How the Company You Keep Drives Leadership Growth & Success” and author of “What Anyone Can Do: How Surrounding Yourself with the Right People Will Drive Change, Opportunity, and Personal Growth.” He earned a bachelor’s degree from Jacksonville University, a master’s degree from Seton Hall, and completed his doctoral coursework in organizational leadership at Northeastern. For a complete detail about the author and his works, visit leobottary.com.

Simon & Schuster, a company with nearly ninety years of publishing experience, has teamed up with Author Solutions, LLC, the worldwide leader in self-publishing, to create Archway Publishing. With unique resources to support books of all kind, Archway Publishing offers a specialized approach to help every author reach his or her desired audience. For more information, visit www.archwaypublishing.com or call 844-669-3957.

Attachment



Marketing Services
Archway Publishing
844-669-3957
[email protected]

NetDragon Wins the Bloomberg Businessweek/Chinese Edition’s “Listed Enterprises of the Year 2020” Award

HONG KONG, Nov. 23, 2020 (GLOBE NEWSWIRE) — NetDragon Websoft Holdings Limited (“NetDragon” or “the Company”, Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that the company has received the “Listed Enterprises of the Year 2020” award at the fifth “Listed Enterprises of the Year 2020” event hosted by the Chinese Edition of Bloomberg Businessweek. The award honours listed enterprises with excellent performance and recognizes their contribution to Hong Kong’s economy. It represents international recognition for NetDragon’s outstanding performance in education and gaming.

Hong Kong is a leading IPO centre in the world as an international financial hub. As a leading business magazine in the region, the Chinese Edition of Bloomberg Businessweek presented the fifth “Listed Enterprises of the Year 2020” event this year. Winners must pass the selection by Bloomberg terminal based on eight criteria, including business/financial performance, corporate governance, investor relationship, development strategy, corporate social responsibility, sustainability, innovation and risk management, and then be assessed by a panel of judges to become “Listed Enterprises of the Year 2020”. This year, it invited 10 leaders from governmental organizations, academic and professional bodies to form the panel of judges. The event was well attended by various listed companies and the winners are all leading companies from a wide range of industries.

The honour of receiving the “Listed Enterprises of the Year 2020” award is a recognition of NetDragon’s business strategy and investment value by the capital market and professional investors. The company has leveraged its strength in technology as well as research and development accumulated over the years in building online communities to proactively expand its reach in the global education market. As the pandemic has accelerated the development of online education this year, the company’s online learning platforms have gained tens of millions of monthly active users, and its blended learning solutions and technology have received tremendous recognition and support by many countries, such as Egypt, Russia, Thailand and Ghana, which have seen the positive impact on their respective pedagogy. Going forward, the company will continue to drive rapid business growth and utilize technology to empower education, with a bid to promote education digitalization globally and education equality.

About
NetDragon
Websoft
Holdings Limited

NetDragon Websoft Holdings Limited (HKSE: 0777) is a global leader in building internet communities with a long track record of developing and scaling multiple internet and mobile platforms that impact hundreds of millions of users, including previous establishments of China’s first online gaming portal, 17173.com, and China’s most influential smartphone app store platform, 91 Wireless.

Established in 1999, NetDragon is one of the most reputable and well-known online game developers in China with a history of successful game titles including Eudemons Online, Heroes Evolved and Conquer Online. In recent years, NetDragon has also started to scale its online education business on the back of management’s vision to create the largest global online learning community, and to bring the “classroom of the future” to every school around the world. For more information, please visit www.netdragon.com.

For investor enquiries, please contact:
NetDragonWebsoft Holdings Limited
Ms. Maggie Zhou
Senior Director of Investor Relations
Tel.: +852 2850 7266 / +86 591 8390 2825
Email: [email protected]
Website: ir.nd.com.cn

 



Former Texas Instruments Executive, Bing Xie Joins Huami’s Board as Independent Director

PR Newswire


BEIJING and CUPERTINO, Calif.
, Nov. 22, 2020/PRNewswire/ — Huami Corp. (NYSE: HMI) today announced that it appointed Mr. Bing Xie, former Texas Instruments (TI) executive officer and senior vice president of worldwide sales and applications, as an independent director on Huami’s board. Mr. Xie will serve on the board’s Audit, Compensation, Nominating, Corporate Governance and the AI and Big Data Ethics Committees.

Over a 21-year career at Texas Instruments, Mr. Xie most recently led the worldwide sales and applications teams. He was previously TI’s president of Greater China (China, Taiwan, Hong Kong). Mr. Xie started his career at Hewlett-Packard, and later joined Bay Networks and 3Com. He has lived and worked in China, Italy, America and Canada. Mr. Xie holds a bachelor of science degree in electronics engineering from Xidian University, and an MBA from Clemson University.

“I am very happy that Xie Bing can join the board of directors,” said Wang Huang, chairman and CEO of Huami Corp.” He has extensive experience and global vision obtained from working with Texas Instruments. With his leadership, I believe he can help Huami better lay out the company’s strategy toward the smart IOT industry, and further promote the implementation of our health and medical strategies.”

Mr. Xie joins current standing board members Mr. De Liu, co-founder and a senior vice president of Xiaomi; Dr. Hongjiang Zhang, retired chief executive officer of Kingsoft (a Hong Kong listed company 03888.HK), former chief technology officer of Asia-Pacific R&D and Distinguished Scientist at Microsoft; Mr. Jimmy Lai, retired chief financial officer of China Online Education Group; Ms. Yunfen Lu, co-founder and vice president of Huami Corp.; and Mr. Xiaojun Zhang, co-founder and vice president of Huami Corp.

About Huami Corporation (NYSE: HMI)

Huami’s mission is to connect health with technology. Since its inception in 2013, Huami has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening line of smart health devices for consumers, and analytics services for industry. In 2019, Huami shipped 37 million smart watches and fitness bands, including its own Amazfit brand, and products developed and manufactured for Xiaomi, comprising 23% of global category shipments[1] . Huami Corp is based in Hefei, China, with U.S. operations, Huami-USA, based in Cupertino, Calif.

For more information, please visit https://www.huami.com/investor/pages/company-profile

[1] IDC, Correcting and Replacing Shipments of Wearable Devices, 3/10/20

For investor and media inquiries, please contact:

In China:
Investors: Grace Zhang, [email protected]
Media: Ken Cao, [email protected]

In the United States:
Investors: Brad Samson, [email protected], 714-955-3951
Media: Lydia Huang, lydia.huang@huami-usa.com, 407-800-5625

Cision View original content:http://www.prnewswire.com/news-releases/former-texas-instruments-executive-bing-xie-joins-huamis-board-as-independent-director-301178611.html

SOURCE Huami Corporation

BIOMARIN 48 HOUR DEADLINE ALERT: ClaimsFiler Reminds Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. – BMRN

BIOMARIN 48 HOUR DEADLINE ALERT: ClaimsFiler Reminds Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. – BMRN

NEW ORLEANS–(BUSINESS WIRE)–
ClaimsFiler, a FREE shareholder information service, reminds investors that they have only untilNovember 24, 2020 to file lead plaintiff applications in a securities class action lawsuit against BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN), if they purchased the Company’s securities between February 28, 2020 and August 18, 2020, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Get Help

BioMarin investors should visit us at https://www.claimsfiler.com/cases/view-biomarin-pharmaceutical-inc-securities-litigation or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

BioMarin and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) differences between the Phase 1/2 and Phase 3 study for its drug candidate, valoctocogene roxaparvovec, limited the reliability of the Phase 1/2 study to support the drug’s durability of effect; (ii) as a result, it was foreseeable that the FDA would not approve the Biologics License Application for valoctocogene roxaparvovec without additional data; and (iii) as a result of the foregoing, BioMarin’s statements were materially false and misleading at all relevant times

The case is Tsantes v. BioMarin Pharmaceutical Inc., et al, 20-cv-06719.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

ClaimsFiler

Lewis Kahn, 844-367-9658

https://www.claimsfiler.com

KEYWORDS: Louisiana United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

OneConnect Launches “Linked Port” in China’s Greater Bay Area

PR Newswire

SHENZHEN, China, Nov. 22, 2020 /PRNewswire/ — OneConnect Financial Technology Co., Ltd. (“OneConnect” or the “Company”) (NYSE: OCFT), an associate of the Ping An Group, and China Merchants Group recently launched the Guangdong-Hong Kong-Macao Greater Bay Area Port Logistics and Trade Facilitation Blockchain Platform Project for the ports Shekou and Shunde.

The “linked port” technology ecosystem for the two ports is the first step to ultimately improve cross-border trade efficiency across the whole Greater Bay Area, one of the world’s largest port zones. With increasing container throughput and cross-border trade, it is vital for the Greater Bay Area to integrate its 37 ports to remain competitive.

The technology project is part of the new infrastructure plan promoted by the Shenzhen municipal government and other governmental departments.

In a promising pilot, 200 twenty-foot equivalents (TEUs) of real goods were imported and exported between the Shekou and Shunde ports. The technology linking the two ports reduced import and export-related logistics processes from five to seven days to just two days. Transportation and customs declaration costs for enterprises also fell by 30%.

The integrated technology linking trade participants operating in the Greater Bay Area will improve communication, streamline port clearance processes and enhance the overall competitiveness of ports within the region.

The linked port project will use advanced technologies, including blockchain, big data, artificial intelligence (AI) and cloud computing, to help create smart ports, and enable smart regulation, smart trade and smart finance processes. OneConnect is a technical supporter of the project. It constructed the core port logistics data standards and the blockchain platform.

Using these technologies, trade participants will be able to connect with customs officials efficiently through a shared blockchain network across the Greater Bay Area. Trade participants will be able to swiftly identify the authenticity of any trade transaction through the validation of cross-border trade-related information registered on the blockchain.

The project focuses on four areas: smart ports, smart regulation, smart trade and smart finance. China Merchants Group’s port in Western Shenzhen will act as a key smart port that allows sharing of resources through blockchain technology, promoting efficient logistics and creating a digital ecosystem for port shipping in the Greater Bay Area.

Smart regulation will improve cooperation between custom officials and enterprises with a collaborative customs clearance process. Two separate customs declaration procedures will be simplified into one, with cross-validation capabilities made possible by blockchain technology and real-time information capture through Internet of Things (IoT)-based processes.

Trading enterprises will also benefit from smart trade solutions for convenient customs clearance, efficient logistics and digital finance, which will create a trust-based, convenient, efficient, and traceable trading environment. Digital financial services such as export tax rebate financing and cross-border e-commerce financing will enhance integrated trade finance services in the Greater Bay Area and build up core competitiveness.

As data on the blockchain cannot be tampered with and allows for automatic cross-verification with the data being encrypted, OneConnect will ensure the logistics data can be traceable and impossible to change. The linked port will greatly enhance authentication processes for logistics and transportation.

The platform will also issue real-time warnings to assist the customs departments in managing any sensitive data regarding ships, containers and cargo.

About OneConnect

OneConnect is a leading technology-as-a-service platform for financial institutions in China. The Company’s platform provides cloud-native technology solutions that integrate extensive financial services industry expertise with market-leading technology. The Company’s solutions provide technology applications and technology-enabled business services to financial institutions. Together they enable the Company’s customers’ digital transformations, which help them increase revenue, manage risks, improve efficiency, enhance service quality and reduce costs.

Our technology-as-a-service platform strategically covers multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses – from sales and marketing and risk management to customer services, as well as technology infrastructure such as data management, program development, and cloud services.

Cision View original content:http://www.prnewswire.com/news-releases/oneconnect-launches-linked-port-in-chinas-greater-bay-area-301178603.html

SOURCE OneConnect

BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine.

SHANGHAI, China, Nov. 23, 2020 (GLOBE NEWSWIRE) — BioShin Limited announced today that the first patients were enrolled in its regional multi-center study, BHV3000-310, being conducted in China and Korea. BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.

Karl Lintel, M.D., Chief Executive Officer of BioShin commented, “We are very pleased to have started enrollment in study BHV300-310. Rimegepant was launched in March 2020 in the USA where its differentiated profile with a rapid onset of action and long-half life is being recognized by patients and providers as an important new treatment option for people suffering with migraine. There has been a lack of innovative treatment for more than two decades for the acute treatment of migraine, and we believe that rimegepant will meet the unmet medical needs of migraine patients in the Asia-Pacific region, as it is doing in the USA.”

“Migraine is a common and serious disease that affects human health,” said Professor Yu Shengyuan, Chief of Neurology at the PLA General Hospital. “According to the results of the World Health Organization (WHO) 2013 Global Burden of Disease Survey published in The Lancet, migraine is the third most common human disease and the first cause of disability in under 50s, and we need new, effective and safe treatment options to help improve the lives of our patients. I believe that rimegepant will be a welcome treatment option for patients and I am encouraged that we are moving one step closer to bringing rimegepant to patients in Asia with the start of study BHV3000-310.”

Professor Byung-kun Kim, investigator at the Nowon Eulji Medical Center in Korea announced, “We are very happy that Nowon Eulji Center has enrolled the first subjects in the BHV 3000-310 study, and we expect that the results of this study will bring new hope to migraine patients suffering with migraine.”

About Migraine

Migraine is a chronic and debilitating disorder characterized by recurrent attacks lasting four to 72 hours with multiple symptoms, including typically one-sided, pulsating headaches of moderate or severe pain intensity that are associated with nausea or vomiting, and/or sensitivity to sound (phonophobia) and sensitivity to light (photophobia). Migraine affects approximately 9% of the adult population in China, comprising 80 TO 90 million adults. The total indirect cost to Chinese society from lost productivity is estimated to be about USD$40 billion. Comorbid conditions associated with migraine include depression, anxiety and cardiovascular disease.

About BHV-3000 
(Rimegepant)

Rimegepant (Nurtec™ ODT) is a calcitonin gene-related peptide (CGRP) receptor antagonist that is being developed for acute migraine treatment. Rimegepant was approved by the US FDA for the acute treatment of migraine in February 2020, and an sNDA has been accepted by the US FDA for the preventive treatment of migraine. The CGRP receptor is located within pain-signaling pathways, intracranial arteries and mast cells and its activation is thought to play a causal role in migraine pathophysiology. Treatment with a CGRP receptor antagonist is believed to relieve migraine through the possible mechanisms of 1) blocking neurogenic inflammation, 2) decreasing artery dilation, and 3) inhibiting pain transmission. This new approach to the treatment of migraine avoids the cardiovascular effects produced by active vasoconstriction associated with the current standard triptan therapy (non-selective 5-HTlB/lD agonists (e.g., sumatriptan [Imitrex™]).

About the BHV3000-310 study

The BHV3000-310 study is an Asia-Pacific multicenter Phase III clinical study. It is a double-blind, randomized, placebo-controlled, safety and efficacy trial of BHV-3000 (rimegepant) for the treatment of migraine in the acute phase. The study obtained a CTA from China’s NMPA on March 20, 2020, and the IND from the Korean FDA on Jun 29, 2020.

About BioShin

BioShin Limited, a privately held biopharmaceutical company with offices in Shanghai, is advancing the Biohaven clinical portfolio in the Asia-Pacific region. BioShin holds rights to the Biohaven portfolio for all of the Asia-Pacific Region, including Australia and New Zealand, excluding Japan. BioShin’s neuroinnovation portfolio includes the US FDA-approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine and a broad pipeline of late-stage product candidates across three distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, Alzheimer’s disease, and spinocerebellar ataxia; and myeloperoxidase inhibition for multiple system atrophy and amyotrophic lateral sclerosis.

Biohaven (NYSE: BHVN) is a majority shareholder in BioShin. More information about BioShin is available at www.bioshin.com

About Biohaven

Biohaven Pharmaceutical Holding Company Ltd (Biohaven) is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. Biohaven has combined internal development and research with intellectual property licensed from companies and institutions including Bristol-Myers Squibb Company, AstraZeneca AB, Yale University, Catalent, Rutgers and ALS Biopharma LLC and. Our progress is fueled by an entrepreneurial organizational structure and an impressive range of experience in drug development along with the confident support of top-tier biopharma investors. Biohaven’s common shares are listed on the New York Stock Exchange and traded under the ticker symbol BHVN. More information about Biohaven is available at www.biohavenpharma.com

Forward-Looking Statements
This release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including “believe”, “continue”, “may”, “will” and similar expressions, are intended to identify forward-looking statements. These forward-looking statements involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of Biohaven’s management about the potential use of Biohaven’s CGRP receptor antagonists as a treatment for patients with plaque psoriasis. Factors that could affect these forward-looking statements include those related to: Biohaven’s ability to effectively develop a CGRP receptor antagonist for the treatment of plaque psoriasis, complying with applicable U.S. regulatory requirements, the expected timing, commencement and outcomes of Biohaven’s planned and ongoing clinical trials, the timing of planned interactions and filings with the FDA, the timing and outcome of expected regulatory filings, the potential commercialization of Biohaven’s product candidates, the potential for Biohaven’s product candidates to be first in class or best in class therapies and the effectiveness and safety of Biohaven’s product candidates. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by our forward-looking statements. Additional important factors to be considered in connection with forward-looking statements are described in the “Risk Factors” section of Biohaven’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 26, 2020 and Biohaven’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the Securities and Exchange Commission on November 9, 2020. The forward-looking statements are made as of this date and Biohaven does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

NURTEC is a trademark of Biohaven Pharmaceutical Ireland DAC.
Karl Lintel
CEO, BioShin
[email protected]
Media Contact:
CHINA – Zoey Wang
General Manager, BioShin
[email protected]



IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients

IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients

POTOMAC, Md.–(BUSINESS WIRE)–
India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2020, which is the second quarter of its 2021 fiscal year, and the start of Phase 1 cannabinoid-based clinical trial for Alzheimer’s Patients.

Revenue in the quarter ended September 30, 2020 and September 30, 2019, were $125 thousand and $1,821 thousand, respectively. The decrease in revenue is primarily due to restrictions imposed by the COVID-19 pandemic. The revenue in the quarter ended September 30, 2020 was approximately 53% from the infrastructure segment and approximately 47% from the Life Science segment. In comparison, the revenue in the September 2019 quarter was primarily from infrastructure. In the past 6 months, our ability to provide services and distribute our products has been impacted due to store closures and abandoned harvests of hemp. Our facility on the West Coast, and our Delhi office, both have had COVID-19 outbreaks that have led to closures, delays, and expenses. In response to the evolving dynamics of the pandemic, we have decreased our staff in select areas, delayed and may terminate the acquisition of Evolve I, Inc., and reoriented our sales focus to online.

In the quarter ended September 30, 2020, our primary focus has been to initiate and carry out the Phase 1 clinical trial on our Investigational Drug Candidate IGC-AD1.

Selling, general and administrative expenses increased by approximately $389 thousand or 36% to $1,483 thousand for three months ended September 30, 2020, from $1,094 thousand for three months ended September 30, 2019. The increase of approximately $0.4 million is attributed to a one-time settlement expense of approximately $50 thousand, compensation expenses attributed to increased head count and associated employee-related expenses, marketing expense related to expansion of brands, and depreciation expense related to increase in Property, Plant and Equipment. We expect general and administrative expenses to decrease as one-time legal and other one-time expenses continue to abate over the rest of this fiscal year.

Net comprehensive loss was approximately $1.5 million or $0.04 per share, for the September 2020 quarter, compared to approximately $1.3 million or $0.03 per share for the September 2019 quarter. Most of the increased loss is attributable to the increased SG&A.

About IGC:

IGC operates two lines of business: (i) infrastructure and (ii) life sciences. The Company is based in Potomac, Maryland, U.S.A. Social media: www.igcinc.us / www.igcpharma.com / Twitter @IGCIR.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on IGC’s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC’s control. For the next several years, our success is highly correlated primarily with the successful outcome of our clinical trials and the recovery of the world and local economies following the COVID-19 pandemic, and, secondarily, on the sale of our products and services candidates. IGC may not be able to complete human trials on our investigational drug candidates, or, once conducted, the results of human trials testing results may not be favorable or as anticipated. Our projections and investments anticipate stable pricing, which may not hold out over the next several years, and certain regulatory changes, specifically in states where medical cannabis has been, is, or will be legalized and the diseases which we anticipate our products will target are approved conditions for treatment or usage with cannabis/ cannabinoids. We may not be able to protect our intellectual property adequately or receive patents. We may not receive regulatory approval for our products, or trials. An additional risk factor worth highlighting specifically related to the patent licensing is that the patent applications we have licensed may not be granted by the United States Patent and Trademark Office (“USPTO”), even if the Company is in full compliance with USPTO requirements. We may not have adequate resources including financial resources, to successfully conduct all requisite clinical trials, to bring a product to market, or to pay applicable maintenance fees over time. We may not be able to successfully commercialize our products even if they are successful and receive regulatory approval. Failure or delay with respect to any of the factors above could have a material adverse effect on our business, future results of operations, our stock price, and our financial condition. Actual results could differ materially from these forward-looking statements as a result of, among other factors, competitive conditions in the industries in which IGC operates; failure to commercialize one or more of the technologies of IGC; general economic conditions that are less favorable than expected; the FDA’s general position regarding hemp-based products; the ongoing COVID-19 pandemic and its effect on global and regional economies in which IGC participates; and other factors, many of which are discussed in IGC’s SEC filings. IGC incorporates by reference the Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on July 13, 2020; Quarterly Reports on Form 10-Q filed with the SEC on August 19, 2020 and November 20, 2020, as if fully incorporated and restated herein. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will in fact occur.

< Financial Tables to Follow >

 

India Globalization Capital, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

(Unaudited)

 

 

 

September 30,

2020

(Unaudited)

($)

 

March 31,

2020

(Audited)

($)

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

1,151

 

 

 

7,258

 

Marketable securities

 

 

3,850

 

 

 

5,081

 

Accounts receivable, net

 

 

241

 

 

 

133

 

Inventory

 

 

6,684

 

 

 

4,245

 

Deposits and advances

 

 

1,761

 

 

 

1,040

 

Total current assets

 

 

13,687

 

 

 

17,757

 

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

 

344

 

 

 

252

 

Property, plant and equipment, net

 

 

10,906

 

 

 

9,780

 

Non-Marketable securities

 

 

261

 

 

 

11

 

Claims and advances

 

 

616

 

 

 

610

 

Operating lease asset

 

 

532

 

 

 

574

 

Total long-term assets

 

 

12,659

 

 

 

11,227

 

Total assets

 

 

26,346

 

 

 

28,984

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

 

975

 

 

 

762

 

Accrued liabilities and others

 

 

727

 

 

 

1,134

 

Short-term loans

 

 

196

 

 

 

50

 

Total current liabilities

 

 

1,898

 

 

 

1,946

 

 

 

 

 

 

 

 

 

 

Long-term loans

 

 

384

 

 

 

 

Other liabilities

 

 

16

 

 

 

16

 

Operating lease liability

 

 

450

 

 

 

485

 

Total non-current liabilities

 

 

850

 

 

 

501

 

Total liabilities

 

 

2,748

 

 

 

2,447

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies – See Note 12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 per value: authorized 1,000,000 shares, no shares issued or outstanding as of September 30, 2020 or March 31, 2020.

 

 

 

 

 

 

Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 41,304,365 and 39,320,116 shares issued and outstanding as of September 30, 2020 and March 31, 2020, respectively.

 

 

95,270

 

 

 

94,754

 

Accumulated other comprehensive loss

 

 

(2,766

)

 

 

(2,850

)

Accumulated deficit

 

 

(68,906

)

 

 

(65,367

)

Total stockholders’ equity

 

 

23,598

 

 

 

26,537

 

Total liabilities and stockholders’ equity

 

 

26,346

 

 

 

28,984

 

See accompanying Notes to the Condensed Consolidated Financial Statements in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, as filed with the SEC on November 20, 2020.

 

India Globalization Capital, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands, except loss per share)

(Unaudited)

 

 

 

Three months ended

September 30,

 

 

Six months ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

125

 

 

 

1,821

 

 

 

709

 

 

 

3,470

 

Cost of revenue

 

 

(99

)

 

 

(1,793

)

 

 

(637

)

 

 

(3,401

)

Gross Profit

 

 

26

 

 

 

28

 

 

 

72

 

 

 

69

 

General and administrative expenses

 

 

(1,483

)

 

 

(1,094

)

 

 

(3,238

)

 

 

(2,343

)

Research and development expenses

 

 

(219

)

 

 

(222

)

 

 

(441

)

 

 

(469

)

Operating loss

 

 

(1,676

)

 

 

(1,288

)

 

 

(3,607

)

 

 

(2,743

)

Other income, net

 

 

19

 

 

 

109

 

 

 

68

 

 

 

185

 

Loss before income taxes

 

 

(1,657

)

 

 

(1,179

)

 

 

(3,539

)

 

 

(2,558

)

Income tax expense/benefit

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders

 

 

(1,657

)

 

 

(1,179

)

 

 

(3,539

)

 

 

(2,558

)

Foreign currency translation adjustments

 

 

142

 

 

 

(143

)

 

 

84

 

 

 

(124

)

Comprehensive loss

 

 

(1,515

)

 

 

(1,322

)

 

 

(3,455

)

 

 

(2,682

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic & Diluted

 

$

(0.04

)

 

 

(0.03

)

 

 

(0.09

)

 

 

(0.06

)

Weighted-average number of shares used in computing loss per share amounts:

 

 

41,244

 

 

 

39,551

 

 

 

40,720

 

 

 

39,529

 

See accompanying Notes to the Condensed Consolidated Financial Statements in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, as filed with the SEC on November 20, 2020.

Claudia Grimaldi

[email protected]

Phone: 301-983-0998

KEYWORDS: Maryland United States North America

INDUSTRY KEYWORDS: Alternative Medicine FDA Health Clinical Trials Pharmaceutical Biotechnology

MEDIA:

NXT-ID, INC. TO ADJOURN ANNUAL MEETING OF STOCKHOLDERS

 

OXFORD, CONNECTICUT, Nov. 22, 2020 (GLOBE NEWSWIRE) —  Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company”) today announced that the Company plans to adjourn the Annual Meeting of Stockholders, scheduled to be held on Monday, November 23, 2020 at 9:00 a.m. (Eastern Time), to Tuesday, November 24, 2020 at 9:00 a.m. (Eastern Time), to be held at the Company’s office at 288 Christian Street, Hangar C 2nd Floor, Oxford CT 06478. The Company is adjourning the Annual Meeting only with respect to Proposals Number 3 and Number 4. The Company will announce such adjournment at the currently scheduled Annual Meeting.

The Company is adjourning the Annual Meeting to allow its retail stockholders additional time to vote and approve Proposals Number 3 and Number 4, which are described in the Proxy Statement. Proposal Number 3 authorizes the Company’s board of directors (the “Board”) to effect, at its discretion, a reverse stock split of the Company’s common stock at a specific ratio within a range from one-for-three to one-for-ten. Proposal Number 4 authorizes the Board to (i) effect a reverse stock split of all of the Company’s outstanding shares of Series C Non-Convertible Voting Preferred Stock by the same ratio that the Company’s Board selects for the reverse stock split of the Company’s common stock described in Proposal Number 3 and (ii) increase the stated value of the Series C Preferred Stock by the same amount as the ratio of the Series C Preferred reverse stock split.

Each stockholder’s vote matters and is important no matter how many shares they own. The Company requests that its stockholders please take the time to read and respond to the Company’s proxy materials that were previously provided to them and vote promptly. Voting over the phone or on the Internet will require that its stockholders have their proxy control number available. That number is either printed on the voting instruction form, if stockholders received a physical copy of the proxy materials, or accessible through the voting portal, if the proxy materials were electronically delivered. Stockholders who have sold their shares but were a holder of record at the close of business on August 17, 2020, the record date for the Annual Meeting, remain entitled to vote. The Company encourages its stockholders who have already voted against the reverse stock splits to please reconsider voting. In particular, the Board encourages stockholders to vote “FOR” each of the proposals. It is critical that each stockholder vote and vote to support these proposals. The integrity of our Company and each stockholder’s investment will suffer tremendously if the Company is delisted; hence the importance of each vote.

Stockholders who need assistance in submitting their proxy or voting their shares should call the Company’s proxy solicitor, Laurel Hill Advisory Group, at 888-742-1305.

About Nxt-ID, Inc.

Nxt-ID, Inc. (NASDAQ: NXTD) provides technology products and services for healthcare applications. The Company has extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization and sensor technologies. Through its subsidiary, LogicMark LLC, Nxt-ID, Inc. is a manufacturer and distributor of non-monitored and monitored personal emergency response systems sold through dealers/distributors and the United States Department of Veterans Affairs. Learn more about Nxt-ID at www.nxt-id.com. For Nxt-ID, Inc. corporate information contact: [email protected].
  
 Forward-Looking Statements for Nxt-ID:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission.

Media Contacts: Vincent S. Miceli
[email protected]



World Leaders and Millions of Citizens Call for Peace at Third Online Rally of Hope

Global Rally of Hope to focused on the 70th Anniversary of the Korean War

Washington, DC, Nov. 22, 2020 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE

World Leaders and Millions of Citizens Call for Peace

at Third Online Rally of Hope

 

Millions of viewers from 194 countries tuned into hundreds of broadcast stations and gathered online today to call for peace among and between nations at an event sponsored by the Universal Peace Federation (UPF) in Korea on Sunday, Nov. 22.  Keynote addresses, prayers, testimonies, flower tributes and world-class entertainment were all hallmarks of the celebrations which made it more real than virtual. The theme was, “Rally of Hope for the Realization of a Heavenly Unified World: Interdependence, Mutual Prosperity and Universal Values.”

Held in commemoration of the 70th anniversary of the Korean War while calling for the peaceful reunification of the Korean Peninsula, the power of hope echoed around the world for a third time in this Rally of Hope series. Previous Rallies were held in August and September. This event showed that the key to realizing this vision of lasting peace was a world that is interdependent with mutual prosperity centered on the universal values of one global family of God.

Dr. Hak Ja Han Moon, co-founder of UPF and keynote speaker in all three Rallies of Hope, outlined two new projects. First, she said, Korean War memorials should be set up in all 63 nations that gave troops, military supplies, medical support or humanitarian aid to Korea at the time of the conflict 70 years ago. Many of these nations have memorials, but not all. Moreover, Dr. Moon said, an online memorial should be established with a registry of all those brave young heroes who served or sacrificed in any way to support Korea during its darkest hour. This project will be launched in 2021, in commemoration of Father and Mother Moon’s visit to North Korea 30 years ago when they directly engaged North Korea’s leader Kim Il Sung exploring a comprehensive roadmap for the peaceful reunification of the Korean Peninsula. 

Second, Dr. Moon announced the establishment of an international association of artists for world peace. This new association will seek to create a culture of gratitude, peace and harmony, beginning with raising sons and daughters of filial piety who live for the sake of others.

Dr. Moon began her address saying, “All around the world, unforeseen and unexpected challenges are erupting in the realms of politics, economy and religious strife that are happening due to COVID-19. We can see the limitations of relying on human efforts alone to solve these problems. The key to achieving a beautiful future is to recognize and welcome our creator, Heavenly Parent, into our lives. God the creator is the Heavenly Parent of humanity.”

The Korean Peninsula is clearly a providential nation, where the will of Heaven can be realized and the only begotten daughter could be protected, she said.  “What wind of good fortune brought the men to defend Korea in 1950? Young veterans came here to protect Korea. We can see through this that God the Creator is working with us. The warriors who shed blood on the battlefront will be eternally remembered in history. They are the heroes of God’s Providence,” she said.

She noted that Korean War veterans are now in their late 80s and 90s, and added that before it is too late she would like to thank the 16 nations that sent troops and all the nations that supplied medical and equipment by holding this Rally of Hope in commemoration of their fight to protect freedom and democracy.

The online rally viewed around the world treated the audience to a dazzling display of musical and dance performances by The Little Angels, the highly acclaimed children’s Korean folk ballet company, as well as remarks by world leaders from a dozen countries. The highlight was a touching tribute in ballet, song and evocative poetry to the veterans of the Korean War.

“I was wounded, left for dead, yet survived,” said Hon. Charles Rangel, a member of U.S. House of Representatives from 1971 to 2017 and a Korean War veteran.

Mr. Rangel said he “never, never” wanted to return to the place that brought him “so much misery and pain.” But as a member of Congress, he did return to Korea where he witnessed South Korea’s rising from ashes to become a symbol of democracy, freedom and economic expansion, and a key ally to the United States. “So, being able to not talk about war today, but 70 years later to talk about peace is so important. God did not create us to destroy each other.” Mr. Rangel said. He said, “I want to thank Mother Moon for the sacrifices she has made in order to create this organization for world peace.”

“To be sure, diplomacy has to play an important role, but I think every person has a role to play in trying to bridge divisions,” said U.S. Ambassador Christopher Hill, who has served as U.S. Ambassador to Iraq and South Korea. “All kinds of people need to come together, as this group suggests, and see what we can all do in our own different ways to deal with these very difficult issues,” he said. He concluded, “I especially want to thank Dr. Moon for her absolutely tireless efforts in raising these issues, and for founding UPF which has done so much to raise the consciousness of the world. She knows better than any of us the tragedy of this war.”

Ethiopia was one of 16 countries who responded to the call from the United Nations to help South Korea repel the North Korean invasion in 1950, said Ethiopian President Sahle-Work Zewde.

The unforgettable bravery and sacrifice of these men and women who fought in that conflict “is a testament to Ethiopia’s unwavering commitment to the principle of collective security enshrined in the United Nations Charter,” Ms. Zewde said.

Canada was also part of the 16-nation UN force — and today, the average age of Korean War veterans is 88 years old, said former Canadian Prime Minister Stephen Harper. “So, let us use whatever opportunities remain to thank them from the bottom of our hearts for what they accomplished.”

Mr. Harper and several other speakers said the COVID-19 pandemic and its resultant economic, financial and medical turmoil stemmed, in part, from a lack of cooperation among nations.

There are hopeful signs to fight the virus, such as treatments and vaccines, Mr. Harper told the Rally of Hope. But it has led to a new climate of unifying and cooperating — even some Middle East countries “have put aside their differences with the signing of the Abraham Accords,” he said.

“We surely can effectively overcome COVID-19 if we join forces,” said former Belgium Prime Minister Yves Leterme, who recalled how more than 3,000 Belgium soldiers joined the UN forces to protect the Korean citizens from the communist invasion.

Colombia was the only Latin American country to join the UN forces, and “and this important action has forged an eternal link with the history of South Korea,” said Colombia’s House of Representative President German Alcides Blanco Alvarez. “The denuclearization of the Korean Peninsula is fundamental,” he said, as it “guarantees a stable and lasting peace, not only for that region of the world, but for the whole world.”

Additional calls for peace were shared by other speakers, including South Sudan President Salva Kiir Mayardit.

In South Sudan, making “total peace” with its sisterly country, Sudan, after 17 years of conflict, contributes to global stability, said Mr. Mayardit.

Although, in El Salvador, “our peace process has been imperfect, we have shown the world that the solution to political crises and internal armed conflict is dialogue and finding agreement among brothers,” said Hon. Mario Ponce, President of the Legislative Assembly of the Republic of El Salvador.

The Rally of Hope began with peace offerings from two religious leaders: “Peace among religions is a precondition for world peace,” said Nasarruddin Umar, Grand Imam of Istiqlal National Mosque of Indonesia. “It is time for religious leadership to lead from the front for reuniting the divided nations and humanity,” said renown Hindu Acharya Shrivatsa Goswami.

Dr. George Mannah Weah, President of the Republic of Liberia, saluted UPF’s efforts as “a leading force for peace in today’s world” as he recalled how his nation has endured “suffering, destruction and devastation caused by war and division.”

The Rally of Hope series is dedicated to “building a unified world of peace,” said UPF Chairman Dr. Thomas G. Walsh. Throughout 2020, UPF chapters around the world have been convening hundreds of programs toward this end, “and over the next two years, those programs will increase dramatically — we need your help,” he said.

UPF, founded in 2005 by Rev. Dr. Sun Myung Moon and Dr. Hak Ja Han Moon, is an NGO in General Consultative Status with the Economic and Social Council of the United Nations.

For additional information please contact:

AFRICA: Mamadou Gaye  [email protected]
ASIA PACIFIC: Robert Kittel  [email protected]
EUROPE & THE MIDDLE EAST: Peter Zoehrer  [email protected]
LATIN AMERICA & CARIBBEAN: Mario Salinas  [email protected]
UNITED STATES & CANADA: Larry Moffitt  [email protected]
 

Attachment



Larry Moffitt
Universal Peace Federation USA
202-669-0387
[email protected]